Are you searching for medications to treat 'Bronchiectasis'? Welcome to this page which serves as an archive for medications that are relevant to the treatment of Bronchiectasis. The page includes ...

The bronchiectasis market report provides current treatment practices, emerging drugs, market share of individual therapies, and current and forecasted 7MM bronchiectasis market size from 2020 to 2034 ...

Explore the latest research on Aspergillus in bronchiectasis, uncovering its prevalence, clinical significance, and potential ...

This review covers the various investigations and aspects of treatment for bronchiectasis and how they may be utilized in a more older and generally frailer population.

Despite significant advances in treatment in recent years ... which ideally have broad potential benefits for people with bronchiectasis and cystic fibrosis. We particularly welcome novel ...

If approved, the drug will be the first approved treatment for bronchiectasis patients, with a product launch expected in mid-2025. Management expects to commercially launch the drug in Europe and ...

and others are evaluating new non-cystic fibrosis bronchiectasis drugs to improve the treatment landscape. Promising pipeline non-cystic fibrosis bronchiectasis therapies such as Colistimethate ...

The phase 3 trial achieved a statistically significant reduction in the frequency of exacerbations in patients with bronchiectasis, a serious, chronic lung disease with no approved treatment that ...

The "Non-cystic fibrosis bronchiectasis - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.The latest comprehensive report on Non-cystic Fibrosis Bronchiectasis (NCFB ...

Patients with bronchiectasis have difficulty clearing mucus from their lungs. There is no approved treatment specifically for ...

and others are evaluating new non-cystic fibrosis bronchiectasis drugs to improve the treatment landscape. Promising pipeline non-cystic fibrosis bronchiectasis therapies such as Colistimethate sodium ...